Promega

CellTiter-Glo® 2.0 Cell Viability Assay

#G8081

100
Citing papers
4.4k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism9Protein Degradation and Inhibitors7Lung Cancer Research Studies6Cancer Cells and Metastasis63D Printing in Biomedical Research6Cancer-related Molecular Pathways6Lung Cancer Treatments and Mutations5Mitochondrial Function and Pathology5

Papers citing this product

1
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Nature·2010·936 cit.·DOI
2
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Journal of Clinical Investigation·2013·469 cit.·DOI
3
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
Nature Communications·2015·201 cit.·DOI
4
Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts
EMBO Molecular Medicine·2015·143 cit.·DOI
5
Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis
Journal of Cancer·2021·136 cit.·DOI
6
GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation
Nature Communications·2022·123 cit.·DOI
7
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer
Cancer Cell·2023·103 cit.·DOI
8
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium
PLoS ONE·2011·99 cit.·DOI
9
ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation
Cell Death and Disease·2017·94 cit.·DOI
10
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Nature Communications·2020·91 cit.·DOI

Similar products

ProductVendorPricePapers
CellTiter-Glo® 2.0 Cell Viability AssayPromega—100
CellTiter-Glo® 2.0 Cell Viability AssayPromega—100
CellTiter-Glo® 2.0 Cell Viability AssayPromega—100
CellTiter-Glo® 2.0 Cell Viability AssayPromega—100
CellTiter-Glo® 2.0 Cell Viability AssayPromega—85
CellTiter-Glo® 2.0 Cell Viability AssayPromega—40
CellTiter-Glo® 2.0 Cell Viability AssayPromega—34
CellTiter-Glo® 2.0 Cell Viability AssayPromega—18
CellTiter-Glo® 2.0 Cell Viability AssayPromega—15
CellTiter-Glo® 2.0 Cell Viability AssayPromega—15
CellTiter-Glo® 2.0 Cell Viability AssayPromega—8
CellTiter-Glo® 2.0 Cell Viability AssayPromega—7
CellTiter-Glo® 2.0 Cell Viability AssayPromega—5
CellTiter-Glo® 2.0 Cell Viability AssayPromega—4